Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,052 | -19,853 | -8,498 | -28,570 | -19,829 |
| Depreciation Amortization | 686 | 434 | 204 | 1,140 | 795 |
| Accounts payable and accrued liabilities | 167 | 204 | 192 | -378 | -440 |
| Other Working Capital | 3,289 | 2,340 | 5 | 350 | -628 |
| Other Operating Activity | 1,752 | 1,138 | 419 | 4,098 | 2,919 |
| Operating Cash Flow | $-24,159 | $-15,738 | $-7,678 | $-23,360 | $-17,184 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -740 | 4,829 | 1,904 | 9,046 | 10,628 |
| PPE Investments | -195 | -104 | -86 | -800 | -652 |
| Other Investing Activity | 0 | 0 | 0 | -6 | 0 |
| Investing Cash Flow | $-935 | $4,725 | $1,819 | $8,240 | $9,977 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 10,000 | 7,500 |
| Common Stock Issued | 48 | 23 | N/A | 40,866 | 21 |
| Other Financing Activity | -4,085 | -2,684 | -1,403 | -4,556 | -1,966 |
| Financing Cash Flow | $-4,037 | $-2,661 | $-1,403 | $46,310 | $5,555 |
| Beginning Cash Position | 48,732 | 48,732 | 48,732 | 17,530 | 17,537 |
| End Cash Position | 19,601 | 35,059 | 41,470 | 48,730 | 15,885 |
| Net Cash Flow | $-29,131 | $-13,673 | $-7,262 | $31,190 | $-1,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,159 | -15,738 | -7,678 | -23,360 | -17,184 |
| Capital Expenditure | -195 | -104 | -86 | -800 | -652 |
| Free Cash Flow | -24,354 | -15,841 | -7,764 | -24,160 | -17,835 |